[1] |
Kallionpää RA, Uusitalo E, Leppävirta J, et al. Prevalence of neurofibromatosis type 1 in the Finnish population[J]. Genet Med, 2018,20(9):1082⁃1086. doi: 10.1038/gim.2017.215.
|
[2] |
Legius E, Messiaen L, Wolkenstein P, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation[J]. Genet Med, 2021,23(8):1506⁃1513. doi: 10.1038/s41436⁃021⁃01170⁃5.
|
[3] |
Kehrer⁃Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants[J]. Hum Genet, 2022,141(2):177⁃191. doi: 10.1007/s00439⁃021⁃02410⁃z.
|
[4] |
中国罕见病联盟Ⅰ型神经纤维瘤病多学科诊疗协作组. Ⅰ型神经纤维瘤病多学科诊治指南(2023版)[J]. 罕见病研究, 2023,2(2):210⁃230. doi: 10.12376/j.issn.2097⁃0501.2023.02. 009.
|
[5] |
Neurofibromatosis[J]. Natl Inst Health Consens Dev Conf Consens Statement, 1987,6(12):1⁃7.
|
[6] |
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy⁃number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020,22(2):245⁃257. doi: 10.1038/s41436⁃019⁃0686⁃8.
|
[7] |
Biasini M, Bienert S, Waterhouse A, et al. SWISS⁃MODEL: modelling protein tertiary and quaternary structure using evolutionary information[J]. Nucleic Acids Res, 2014,42(Web Server issue):W252⁃258. doi: 10.1093/nar/gku340.
|
[8] |
Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS⁃MODEL and Swiss⁃PdbViewer: a historical perspective[J]. Electrophoresis, 2009,30 Suppl 1:S162⁃173. doi: 10.1002/elps.200900140.
|
[9] |
Peduto C, Zanobio M, Nigro V, et al. Neurofibromatosis type 1: pediatric aspects and review of genotype⁃phenotype correlations[J]. Cancers (Basel), 2023,15(4):1217. doi: 10.3390/cancers 15041217.
|
[10] |
N Abdel⁃Aziz N, Y El⁃Kamah G, A Khairat R, et al. Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1[J]. Mol Genet Genomic Med, 2021,9(12):e1631. doi: 10.1002/mgg3.1631.
|
[11] |
Jouhilahti EM, Peltonen S, Heape AM, et al. The pathoetiology of neurofibromatosis 1[J]. Am J Pathol, 2011,178(5):1932⁃1939. doi: 10.1016/j.ajpath.2010.12.056.
|
[12] |
Albaghdadi M, Thibodeau ML, Lara⁃Corrales I. Updated approach to patients with multiple café au lait macules[J]. Dermatol Clin, 2022,40(1):9⁃23. doi: 10.1016/j.det.2021.08.002.
|
[13] |
Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care[J]. Lancet Neurol, 2014,13(8):834⁃843. doi: 10.1016/S1474⁃4422(14)70063⁃8.
|
[14] |
Ferrari F, Masurel A, Olivier⁃Faivre L, et al. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1[J]. JAMA Dermatol, 2014,150(1):42⁃46. doi: 10.1001/jamadermatol.2013.6434.
|
[15] |
Ozarslan B, Russo T, Argenziano G, et al. Cutaneous findings in neurofibromatosis type 1[J]. Cancers (Basel), 2021,13(3):463. doi: 10.3390/cancers13030463.
|
[16] |
Mallone F, Alisi L, Lucchino L, et al. Insights into novel choroidal and retinal clinical signs in neurofibromatosis type 1[J]. Int J Mol Sci, 2023,24(17):13481. doi: 10.3390/ijms2417 13481.
|
[17] |
Ragge NK, Falk RE, Cohen WE, et al. Images of Lisch nodules across the spectrum[J]. Eye (Lond), 1993,7 ( Pt 1):95⁃101. doi: 10.1038/eye.1993.20.
|
[18] |
Bizzarri C, Bottaro G. Endocrine implications of neurofibro⁃matosis 1 in childhood[J]. Horm Res Paediatr, 2015,83(4):232⁃241. doi: 10.1159/000369802.
|
[19] |
Hannah⁃Shmouni F, Stratakis CA. Growth hormone excess in neurofibromatosis 1[J]. Genet Med, 2019,21(5):1254⁃1255. doi: 10.1038/s41436⁃018⁃0312⁃1.
|
[20] |
中华医学会儿科学分会内分泌遗传代谢学组, 中华儿科杂志编辑委员会. 中枢性性早熟诊断与治疗专家共识(2022)[J]. 中华儿科杂志, 2023,61(1):16⁃22. doi: 10.3760/cma.j.cn112140⁃ 20220802⁃00693.
|
[21] |
Toro G, Santoro C, Ambrosio D, et al. Natural history of scoliosis in children with NF1: an observation study[J]. Healthcare (Basel), 2021,9(7):881. doi: 10.3390/healthcare9070881.
|
[22] |
Neifert SN, Khan HA, Kurland DB, et al. Management and surgical outcomes of dystrophic scoliosis in neurofibromatosis type 1: a systematic review[J]. Neurosurg Focus, 2022,52(5):E7. doi: 10.3171/2022.2.FOCUS21790.
|
[23] |
Vogel AC, Gutmann DH, Morris SM. Neurodevelopmental disorders in children with neurofibromatosis type 1[J]. Dev Med Child Neurol, 2017,59(11):1112⁃1116. doi: 10.1111/dmcn.13526.
|
[24] |
Al⁃Farsi F, Al⁃Alyani O, Al⁃Kumzari A, et al. Systemic review and meta⁃analysis of the intellectual integrity of children with neurofibromatosis type 1[J]. World Neurosurg, 2022,157:69⁃74. doi: 10.1016/j.wneu.2021.10.081.
|
[25] |
Wang W, Qin W, Ge H,et al.Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1[J].Mol Biol Rep, 2019,46(4):4349⁃4359. doi: 10.1007/s11033⁃019⁃04888⁃3.
|
[26] |
Mao B, Chen S, Chen X, et al. Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1[J]. BMC Med Genet, 2018,19(1):101. doi: 10.1186/s12881⁃018⁃0615⁃8.
|
[27] |
Upadhyaya M, Huson SM, Davies M, et al. An absence of cutaneous neurofibromas associated with a 3⁃bp inframe deletion in exon 17 of the NF1 gene (c.2970⁃2972 delAAT): evidence of a clinically significant NF1 genotype⁃phenotype correlation[J]. Am J Hum Genet, 2007,80(1):140⁃151. doi: 10.1086/510781.
|
[28] |
Koczkowska M, Callens T, Gomes A, et al. Expanding the clinical phenotype of individuals with a 3⁃bp in⁃frame deletion of the NF1 gene (c.2970_2972del): an update of genotype⁃phenotype correlation[J]. Genet Med, 2019,21(4):867⁃876. doi: 10.1038/s41436⁃018⁃0269⁃0.
|
[29] |
Rojnueangnit K, Xie J, Gomes A, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype⁃phenotype correlation[J]. Hum Mutat, 2015,36(11):1052⁃1063. doi: 10.1002/humu.22832.
|
[30] |
Well L, Döbel K, Kluwe L, et al. Genotype⁃phenotype correlation in neurofibromatosis type⁃1: NF1 whole gene deletions lead to high tumor⁃burden and increased tumor⁃growth[J/OL]. PLoS Genet, 2021,17(5):e1009517. doi: 10.1371/journal.pgen.1009517.
|
[31] |
Koczkowska M, Chen Y, Callens T, et al. Genotype⁃phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844⁃848[J]. Am J Hum Genet, 2018,102(1):69⁃87. doi: 10.1016/j.ajhg.2017.12.001.
|
[32] |
祝英, 郭韫懿, 张丹露, 等. 表型温和的1型神经纤维瘤病:5个家系基因突变分析[J]. 中华皮肤科杂志, 2022,55(6):519⁃522. doi: 10.35541/cjd.20201263.
|